e-learning
resources
Vienna 2009
Monday, 14.09.2009
Impact of biomarkers in the management of community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of biomarkers and SOFA score prognostic value in ventilator-associated pneumonia
R. Seligman, S. Kretzer, V. Martins, L. F. Lima, V. Oliveira, C. Sanvicente, E. Pacheco, J. Sartori, K. Dalla Rosa, L. Restelatto, B. Seligman (Porto Alegre, Brazil)
Source:
Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Session:
Impact of biomarkers in the management of community-acquired pneumonia
Session type:
Oral Presentation
Number:
1785
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Seligman, S. Kretzer, V. Martins, L. F. Lima, V. Oliveira, C. Sanvicente, E. Pacheco, J. Sartori, K. Dalla Rosa, L. Restelatto, B. Seligman (Porto Alegre, Brazil). Comparison of biomarkers and SOFA score prognostic value in ventilator-associated pneumonia. Eur Respir J 2009; 34: Suppl. 53, 1785
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Correlation of procalcitonin and CRP in community-acquired pneumonia with CRB-65 score and prognosis – results from the German competence network CAPNETZ
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006
Predictive value of procalcitonin in ventilator-associated pneumonia
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007
Prognostic value of procalcitonin in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 384
Year: 2011
Oxy-Met score: a new physiological index to predict mortality in community-acquired pneumonia
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017
CUR-65 score for community-acquired pneumonia predicted mortality better than CURB-65 score in low-mortality-rate settings
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Performance of the CORB score for predicting clinical outcomes in community-acquired pneumonia.
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
Does the use of the CURB-65 score improve outcomes in community-acquired pneumonia (CAP)?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Specific treatment failure of the ventilator-associated pneumonia (VAP): predictive values
Source: Eur Respir J 2006; 28: Suppl. 50, 786s
Year: 2006
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 groups at risk
Source: Eur Respir J 2007; 30: Suppl. 51, 481s
Year: 2007
The prognostic value of the Charlson’s comorbidity index in patients with bacteremic pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Validation of indices and predictive rules of severity for community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 560s
Year: 2002
Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia
Source: Eur Respir J 2008; 31: 356-362
Year: 2008
Comparison of the predictive rules PSI and CRB-65 for assessing severity of community-acquired pneumonia among patients over 65 years
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Prediction of clinical severity and outcome of ventilator-associated pneumonia in a tertiary hospital using the VAP PIRO scoring system
Source: Annual Congress 2011 - Pulmonary infections and sepsis
Year: 2011
Comparision of procalcitonin and CURB-65 in pneumonia
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
MR-proANP and prognosis of ventilator-associated pneumonia
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007
Predicting severe sepsis in community-acquired pneumonia using CURB65 and PSI scores
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Fine score is superior to CURB-65 in predicting severity of pneumonia
Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept